Giant Biogene Holding Co., Ltd. announced that it has received investment in a round of funding in 2021. The transaction included participation from new investor Legend Capital Management Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52 HKD | -1.05% | 0.00% | +46.07% |
Apr. 30 | Giant Biogene’s Profit Up 47% in 2023 | MT |
Mar. 26 | Giant Biogene to Pay Special 0.45 Yuan per Share Dividend | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.07% | 6.56B | |
+13.19% | 394B | |
+13.53% | 134B | |
+18.50% | 78.02B | |
-11.38% | 66.3B | |
-7.89% | 47.33B | |
-5.43% | 39.33B | |
+8.33% | 35.5B | |
+12.28% | 18.09B | |
+18.31% | 16.17B |
- Stock Market
- Equities
- 2367 Stock
- News Giant Biogene Holding Co., Ltd.
- Giant Biogene Holding Co., Ltd. announced that it has received funding from Legend Capital Management Co., Ltd.